901 related articles for article (PubMed ID: 16364838)
1. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
Mahmud A; Mahgoub M; Hall M; Feely J
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
[TBL] [Abstract][Full Text] [Related]
2. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension.
Mahmud A; Feely J
Am J Hypertens; 2005 Jan; 18(1):50-5. PubMed ID: 15691617
[TBL] [Abstract][Full Text] [Related]
3. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
Hood SJ; Taylor KP; Ashby MJ; Brown MJ
Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
[TBL] [Abstract][Full Text] [Related]
4. RGS2 expression and aldosterone: renin ratio modulate response to drug therapy in hypertensive patients.
Semplicini A; Strapazzon G; Papparella I; Sartori M; Realdi A; Macchini L; Calò LA; Ceolotto G
J Hypertens; 2010 May; 28(5):1104-8. PubMed ID: 20375904
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of add-on aldosterone receptor blocker in uncontrolled hypertension.
Sharabi Y; Adler E; Shamis A; Nussinovitch N; Markovitz A; Grossman E
Am J Hypertens; 2006 Jul; 19(7):750-5. PubMed ID: 16814132
[TBL] [Abstract][Full Text] [Related]
6. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
7. Menopause not aldosterone-to-renin ratio predicts blood pressure response to a mineralocorticoid receptor antagonist in primary care hypertensive patients.
Olivieri O; Pizzolo F; Ciacciarelli A; Corrocher R; Signorelli D; Falcone S; Blengio GS
Am J Hypertens; 2008 Sep; 21(9):976-82. PubMed ID: 18600211
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone/renin ratio determines peripheral and central blood pressure values over a broad range.
Tomaschitz A; Maerz W; Pilz S; Ritz E; Scharnagl H; Renner W; Boehm BO; Fahrleitner-Pammer A; Weihrauch G; Dobnig H
J Am Coll Cardiol; 2010 May; 55(19):2171-80. PubMed ID: 20447545
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone to renin ratio as a determinant of exercise blood pressure response in hypertensive patients.
Lim PO; Donnan PT; MacDonald TM
J Hum Hypertens; 2001 Feb; 15(2):119-23. PubMed ID: 11317191
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of a raised aldosterone-renin ratio (ARR) among new referrals to a hypertension clinic.
Williams D; Croal B; Furnace J; Ross S; Witte K; Webster M; Critchen W; Webster J
Blood Press; 2006; 15(3):164-8. PubMed ID: 16864158
[TBL] [Abstract][Full Text] [Related]
11. Effect of combined angiotensin-converting enzyme and aldosterone inhibition on plasma plasminogen activator inhibitor type 1 levels in chronic hypertensive patients.
Tiryaki O; Usalan C; Buyukhatipoglu H
Nephrology (Carlton); 2010 Mar; 15(2):211-5. PubMed ID: 20470281
[TBL] [Abstract][Full Text] [Related]
12. The influence of serum aldosterone and the aldosterone-renin ratio on pulse wave velocity in hypertensive patients.
Park S; Kim JB; Shim CY; Ko YG; Choi D; Jang Y; Chung N
J Hypertens; 2007 Jun; 25(6):1279-83. PubMed ID: 17563542
[TBL] [Abstract][Full Text] [Related]
13. Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study.
Lim PO; Jung RT; MacDonald TM
Br J Clin Pharmacol; 1999 Nov; 48(5):756-60. PubMed ID: 10594479
[TBL] [Abstract][Full Text] [Related]
14. Does the aldosterone:renin ratio predict the efficacy of spironolactone over bendroflumethiazide in hypertension? A clinical trial protocol for RENALDO (RENin-ALDOsterone) study.
Parthasarathy HK; Alhashmi K; McMahon AD; Struthers AD; Connell JM; McInnes GT; Ford I; MacDonald TM
BMC Cardiovasc Disord; 2007 May; 7():14. PubMed ID: 17490489
[TBL] [Abstract][Full Text] [Related]
15. The effect of spironolactone in hypertensive patients on regular haemodialysis and after renal allotransplantation.
Papadimitriou M; Vyzantiadis A; Milionis A; Memmos D; Metaxas P
Life Support Syst; 1983; 1(3):197-205. PubMed ID: 6433115
[TBL] [Abstract][Full Text] [Related]
16. The effects of thiazide and thiazide-potassium sparing diuretics on fibrinolytic system parameters.
Kaşifoğlu T; Yalçin AU
Anadolu Kardiyol Derg; 2006 Jun; 6(2):143-7. PubMed ID: 16766279
[TBL] [Abstract][Full Text] [Related]
17. [Relationship of the renin-angiotensin-aldosterone system with auricular natriuretic factor in its response to the action of thiazide diuretics and to nifedipine, a sustained-release calcium antagonist].
Ocón J; Mora-Macià J; Castellet R; del Río G
Med Clin (Barc); 1994 Jan; 102(2):41-5. PubMed ID: 8133694
[TBL] [Abstract][Full Text] [Related]
18. Does the ratio of serum aldosterone to plasma renin activity predict the efficacy of diuretics in hypertension? Results of RENALDO.
Parthasarathy HK; Alhashmi K; McMahon AD; Struthers AD; McInnes GT; Ford I; Connell JM; MacDonald TM
J Hypertens; 2010 Jan; 28(1):170-7. PubMed ID: 20009770
[TBL] [Abstract][Full Text] [Related]
19. Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives.
Lamarre-Cliche M; de Champlain J; Lacourcière Y; Poirier L; Karas M; Larochelle P
Am J Hypertens; 2005 Jan; 18(1):56-64. PubMed ID: 15691618
[TBL] [Abstract][Full Text] [Related]
20. [Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients].
Chen SX; Du YL; Zhang J; Gong YC; Hu YR; Chu SL; He QB; Song YY; Zhu DL
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):868-72. PubMed ID: 17217708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
